Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 1 Chapter X. References Abajo, P., C. Feal, T. Sanz Sanchez, J. Sanchez Perez and A. Garcia Diez. 1999. Eczematous erythroderma induced by cyanamide. Contact Dermatitis. 40( 3): 160 1.

ACGIH. 1996. American Council of Governmental Industrial Hygienists. Documentation of threshold limit values and biological exposure indices. Hydrogen cyanide and cyanide salts.

ACGIH. 1991. American Council of Governmental Industrial Hygienists. Documentation of threshold limit values and biological exposure indices. Cyanogen chloride.

Aitken, D., D. West, F. Smith, W. Poznanski, J. Cowan, J. Hurtig, E. Peterson and B. Benoit. 1977. Cyanide toxicity following nitroprusside induced hypotension. Can Anaesth Soc J 24: 651 660. ( As cited in ATSDR, 1997.)

Ajima, M., K. Usuki, A. Igarashi, R. Okazaki, K. Hamano, A. Urabe and Y. Totsuka. 1997. Cyanamide induced granulocytopenia. Internal Med 36( 9): 640 2.

Albert, R. E., A. R. Sellakumar, S. Laskin, M. Kuschner, N. Nelson and C. A. Snyder. 1982. Gaseous formaldehyde and hydrogen chloride induction of nasal cancer in rats. J Natl Cancer Inst 68( 4): 597 603.

Aldridge, W. N. and C. L. Evans. 1946. The physiological effects and fate of cyanogen chloride. Q J Exp Physiol 33: 241 266.

Aldridge, W. N. 1951. The conversion of cyanogen chloride to cyanide in the presence of blood proteins and sulphydryl compounds. Biochem J 48: 271 276.

Aletor, V. A. 1993. Cyanide in garri. 1. Distribution of total, bound and free hydrocyanic acid in commercial garri, and the effect of fermentation time on residual cyanide content. Int J Food Sci Nutr 44( 4): 281 287.

Ali, F., and T. N. Persaud. 1987. Mechanisms of alcohol embryopathy: Role of acetaldehyde. Teratology 36( 1): 20A. ( abstract)

Anderson, R. C. and K. K. Chen. 1940. Absorption and toxicity of sodium and potassium thiocyanates. J Am Pharm Assoc 29: 152 161.

Andrews, J. M., E. S. Sweeney, T. C. Grey and T. Wetzel. 1989. The biohazard potential of cyanide poisoning during postmortem examination. J Foresic Sci 34: 1280 1284. ( As cited in ATSDR, 1997.)

Anonymous. 1990. Health assessment for ALSCO Anaconda National priorities list. NTIS BP90 100330. ( As cited in ATSDR, 1997.) Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 2 ATSDR. 1997. Toxicological Profile for Cyanide ( Update). U. S. Department of Health and Human Services, Public Health Service. September.

Ayman, D. 1931. Potassium thiocyanate in the treatment of essential hypertension. J Am Med Assoc 96: 1852 1857.

Bala, T. S., M. K. Janardanasarma and M. Raghunath. 1996. Dietary goitrogen induced changes in the transport of 2 deoxy D glucose and amino acids across the rat blood brain barrier. Int J Dev Neurosci 14( 5): 575 83.

Ballantyne, B. 1988. Toxicology and hazard evaluation of cyanide fumigation powders. Clin Toxicol 26: 325 335 ( As cited in ATSDR, 1997)

Banerjee, K. K., P. Marimuthu, P. Bhattacharyya and M. Chatterjee. 1997. Effect of thiocyanate ingestion through milk on thyroid hormone homeostasis in women. Br J Nutr 78( 5): 679 81.

Barker, M. H. 1936. The blood cyanates in the treatment of hypertension. J Am Med Assoc 106( 10): 762 767.

Barker, M. H., H. A. Lindberg and M. H. Wald. 1941. Further experiences with thiocyanates. J Am Med Assoc 117( 19): 1591 1594.

Barrow, C. S., Y. Alarie, J. C. Warrick and M. F. Stock. 1977. Comparison of the sensory irritation response in mice to chlorine and hydrogen chloride. Arch Environ Health 32( 2): 68 76.

Basu, T. K. 1983. High dose ascorbic acid decreases detoxification of cyanide derived from amygdalin ( laetrile): Studies in guinea pigs. Can J Physiol Pharmacol 61: 1426 1430.

Beamish, R. E., W. F. Perry and V. M. Storrie. 1954. Observations on thyroid function in hypertensive patients treated with potassium thiocyanate. Am Heart J 48: 433 438.

Beaumont, J. J., J. Leveton, K. Knox, T. Bloom, T. McQuiston, M. Young, R. Goldsmith, N. K. Steenland, D. P. Brown and W. E. Halperin. 1987. Lung cancer mortality in workers exposed to sulfuric acid mist and other acid mists. J Nat Cancer Inst 79( 5): 911 921.

Bhattacharya, R., P. Kumar and A. S. Sachan. 1994. Cyanide induced changes in dynamic pulmonary mechanics in rats. Indian J Physiol Pharmacol 38( 4): 281 4.

Blackburn, C. M., F. R. Keating and S. F. Haines. 1951. Radioiodine tracer studies in thiocyanate myxedema. J Clin Endocrinol 11: 1503 1511.

Blanc, P., M. Hogan, K. Malin, D. Hryhorczuk, S. Hessl and B. Bernard. 1985. Cyanide Intoxication Among Silver Reclaiming Workers. JAMA 253( 3): 367 371. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 3 Bond, G. G., G. H. Flores, B. A. Stafford and G. W. Olsen. 1991. Lung cancer and hydrogen chloride exposure: results from a nested case control study of chemical workers. J Occup Med 33( 9): 958 961.

Bookallil, M. J. 2001. PH of the Blood: Acid Base Balance. The University of Sydney. http:// www. usyd. edu. au/ su/ anaes/ lectures/ acidbase_ mjb/ frameversion. html Boorman, G. A. 1998. Memorandum to Dr. Stokes, Chairperson, Protocol Review Committee regarding cyanogen chloride studies. April 24, 1998.

Bottoms, S. F., B. R. Kuhnert, P. M. Kuhnert and A. L. Reese. 1982. Maternal passive smoking and fetal serum thiocyanate levels. Am J Obstet Gynecol 144( 7): 787 791. ( As cited in ATSDR, 1997.)

Boulos, B. M., F. Hanna, L. E. Davis and A. H. Almond. 1973. Placental transfer of antipyrine and thiocyanate and their use in determining maternal and fetal body fluids in a maintained pregnancy. Arch Int Pharm Acodyn Ther 201: 42 51.

Buckley, L. A., X. Z. Jiang, R. A. James, K. T. Morgan and C. S. Barrow. 1984. Respiratory tract lesions induced by sensory irritants at the RD50 concentration. Toxicol Appl Pharmacol 74: 417 429.

Bujan, J. J. G., J. Y. Bayona, and R. S. Arechavala. 1994. Allergic contact dermatitis from cyanamide: Report of 3 cases. Contact Dermatitis 31: 331 332.

Burleigh Flayer, H., K. L. Wong and Y. Alarie. 1985. Evaluation of the pulmonary effects of hydrochloric acid using carbon dioxide challenges in guinea pigs. Fund Appl Toxicol 5( 5): 978 985.

Callahan, M. A., M. W. Slimak, N. W. Gabel, et al. 1979. Water related environmental fate of 129 priority pollutants. Vol. 1. U. S. Environmental Protection Agency, Office of Water Planning and Standards, Office of Water and Waste Management, Washington, DC. ( As cited in ATSDR, 1997.)

Carella, F., M. P. Grassi, M. Savoiardo, P. Contri, B. Rapuzzi and A. Mangoni. 1988. Dystonic Parkinsonian Syndrome After Cyanide Poisoning: Clinical and MRI Findings. J Neurol Neurosurg Psychiatry 51: 1345 1348.

Chan, J. C. 1983. Acid base disorders and the kidney. Adv Pediatr 30: 401 71.

Chan, S. and M. D. Kilby. 2000. Thyroid hormone and central nervous system development. J Endocrin 165: 1 8 Chandra, H., B. N. Gupta and N. Mathur. 1988. Threshold limit value of cyanide: A reappraisal in Indian context. Indian J Environ Protection 8: 170 174. ( As cited in ATSDR, 1997.) Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 4 Chandra, H., B. N. Gupta, S. K. Bhargava, S. H. Clerk, and P. N. Mahendra. 1980. Chronic cyanide exposure  A biochemical and industrial hygiene study. J Analyt Toxicol 4: 161 165.

Charache, S., T. P. Duffy, N. Jander, J. C. Scott, M. Bedine and R. Morrell. 1975. Toxictherapeutic ratio of sodium cyanate. Arch Internal Med 135( 8): 1043 7.

Chemfinder. 2001. Online at www. chemfinder. com.

Chen, Y., L. L. Pederson and N. M. Lefcoe. 1990. Exposure to environmental tobacco smoke ( ETS) and serum thiocyanate level in infants. Arch Environ Health 45( 3): 163 167. ( As cited in ATSDR, 1997.)

Cicerone, R. J. and Zellner R. 1983. The atmospheric chemistry of hydrogen cyanide ( HCN). J Geophys Res 88: 10689 10696. ( As cited in ATSDR, 1997.)

Cipollaro, M., G. Corsale, A. Esposito, E. Ragucci, N. Staiano, G. G. Giordano and G. Pagano. 1986. Sublethal pH decrease may cause genetic damage to eukaryotic cell: a study on sea urchins and Salmonella typhimurium. Teratogen Carcinogen Mutagen 6( 4): 275 87.

Clausing, P. and M. Gottschalk. 1989. Effects of drinking water acidification, restriction of water supply and individual caging on parameters of toxicological studies in rats. Zeitschrift Fur Versuchstierkunde 32( 3): 129 34.

Cliff, J., D. Nicala, F. Saute, R. Givragy, G. Azambuja, A. Taela, L. Chavane, and J. Howarth. 1997. Konzo associated with war in Mozambique. Trop Med Int Health 2( 11): 1068 1074.

Cole, R. H., R. E. Frederick, R. P. Healy et al. 1984. Preliminary findings of the priority pollutant monitoring project of the nationwide urban runoff program. J Water Pollut Control Fed 56: 898 908. ( As cited in ATSDR, 1997.)

Conde Salazar, L., D. Guimaraens, L. Romero and A. Harto. 1981. Allergic contact dermatitis to cyanamide ( carbodiimide). Contact Dermatitis 7( 6): 329 330.

Crutzen, P. J. and G. R. Carmichael. 1993. Modeling the influence of fires on atmospheric chemistry. In: Crutzen, P. J. and J. G. Goldammer, eds. Fire in the Environment: The Ecological, Atmospheric and Climatic Importance of Vegetation Fires. John Wiley and Sons, LTD. pp. 89 105. ( As cited in ATSDR, 1997.)

Dahlberg, P. A., A. Bergmark, L. Bjorck, A. Bruce, L. Hambraeus and O. Claesson. 1984. Intake of thiocyanate by way of milk and its possible effect on thyroid function. Am J Clin Nutr 39( 3): 416 20.

Darmer, K. I., E. R. Kinkead and L. C. Dipasquale. 1974. Acute toxicity in rats and mice exposed to hydrogen chloride gas and aerosols. Am Ind Hyg Assoc J 35( 10): 623 631. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 5 De Flora, S. 1981. Study of 106 organic and inorganic compounds in the Salmonella/ microsome test. Carcinogenesis 2: 283 298. ( As cited in ATSDR, 1997)

De Flora, S., A. Camoirano, P. Zanacchi and C. Bennicelli. 1984. Mutagenicity testing with TA97 and TA102 of 30 DNA damaging compounds, negative with other Salmonella strains. Mutat Res. 134: 159 165. ( As cited in ATSDR, 1997).

De Groot, A. P., M. I. Willems and R. H. de Vos. 1991. Effects of high levels of brussels sprouts in the diet of rats. Food Chem Toxicol 29( 12): 829 37.

Deitrich, RA., P. A. Troxell, W. S. Worth, and V. G. Erwin. 1976. Inhibition of aldehyde dehydrogenase in brain and liver by cyanamide. Biochem Pharmacol 25: 2733 2737. ( As cited in Mertschenk et al., 1991).

Deschamps, D., P. Soler, N. Rosenberg, F. Baud and P. Gervais. 1994. Persistent asthma after inhalation of a mixture of sodium hypochlorite and hydrochloric acid. Chest 105( 6): 1895 6.

Devlin, D. J., J. W. Mills and R. P. Smith. 1989a. Histochemical Localization of Rhodanese Activity in Rat Liver and Skeletal Muscle. Toxicol Appl Pharmacol 97: 247 255.

Devlin, D. J., R. P. Smith and C. D. Thron. 1989b. Cyanide metabolism in the isolated, perfused, bloodless hindlimbs or liver of the rat. Toxicol Appl Pharmacol 98( 2): 338 49.

Domzalski, C. A., L. C. Kolb and E. A. Hines. 1953. Delerious reactions secondary to thiocyanate therapy of hypertension. Staff Meetings of the Mayo Clinic 28( 9): 272 280.

Dourson, M. L. 1994. Methods for establishing oral reference doses ( RfDs). In: Merts, W., C. O. Abernathy and S. S. Olin, eds. Risk assessment of essential elements. Washington, DC: ILSI Press, pp. 51 61.

Drawbaugh, R. B. and T. C. Marrs. 1987. Interspecies differences activity in liver, kidney and plasma. Comp Biochem Physiol 85B( 2): 307 310.

Drinker. P. 1932. Hydrocyanic acid gas poisoning by absorption through the skin. J Ind Hyg 14: 1 2.

Edwards, J. O., T. E. Erstfeld, K. M. Ibne Rasa, G. Levey, and M. Moyer. 1986. Reaction rates for nucleophiles with cyanogen chloride; Comparison with two other digonal carbon compounds. Int J Chem Kinetics 18: 165 180.

Einhorn, I. N. and G. Moore. 1990. Utilization of neurophysiological protocols to characterize soldier response to irritant gases. Phase 1. Northeast Research Institute, Inc. p. 91 NTIS/ AD B160773. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 6 El Ghawabi, S. H., M. A. Gaafar, A. A. El Saharti, S. H. Ahmed, K. K. Malash and R. Fares. 1975. Chronic Cyanide Exposure: A Clinical, Radioisotope and Laboratory Study. Br J Ind Med 32: 215 219.

Ermans, A. M., F. Delange, M. Vander Velden and J. Kinthaert. 1980. Possible Role of Cyanide and Thiocyanate in The Etiology of Endemic Cretinism. Adv Exp Med Biol 30: 455 486.

Ferguson, H. C. 1962. Dilution of dose and acute oral toxicity. Toxicol Appl Pharmacol. 4: 759 762. ( as cited in ATSDR, 1997)

Fiksel, J., C. Cooper, A. Eschenroeder, et al. 1981. Exposure and risk assessment for cyanide. EPA/ 440/ 4 85/ 008. NTIS PB85 220572. ( As cited in ATSDR, 1997.)

Flury, F. and F. Zernik. 1931. Noxious gases: Vapors, mist, smoke and dust particles. With authorized use of the work Noxious gases by Henderson and Haggard. Berlin: Publishing house of Julius Springer, pp. 340 351.

GEOMET Technologies, Inc. 1981. Hydrogen chloride: Report 4, occupational hazard assessment. U. S. Department of Health and Human Services, NIOSH, Cincinnati, OH. NTIS PB83 105296.

Goday Bujan, J. J., I. Yanguas Bayona and R. Soloeta Arechavala. 1994. Allergic contact dermatitis from cyanamide: Report of 3 cases. Contact Dermatitis 31( 5): 331 2.

Goldring, W. and H. Chasis. 1931. The use of sulphocyanate in the treatment of hypertension. NY State J Med 31: 1322 1324.

Gorman, W. F, E. Messinger and M. Herman. 1949. Toxicity of thiocyanates used in treatment of hypertension. Ann Intern Med 30: 1054 1059.

Grandas, F., J. Artieda and J. A. Obeso. 1989. Clinical and CT Scan Findings in a Case of Cyanide Intoxication. Movement Disorders 4( 2): 188 193.

Graziano, J. H., Y. S. Thornton, J. K. Leong and A. Cerami. 1973. Pharmacology of cyanate. 2. Effects on the endocrine system. J Pharmacol Exp Ther 185: 667 675.

Great Lakes Water Quality Board. 1983. An inventory of chemical substances identified in the Great Lakes ecosystem. Vol. 1. Summary Report to the Great Lakes Water Quality Board. Windsor Ontario, Canada 195. ( As cited in ATSDR, 1997.)

Guillen, F. J. and J. J. Vazquez. 1984. Cyanamide induced liver cell injury. Experimental study in the rat. Lab Invest 50( 4): 385 93. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 7 Haddow, J. E., G. E. Palomake, W. C. Allan, J. R. Williams, G. J. Knight, J. Gagnon, C. E. O'Heir, M. L. Mitchell, R. J. Hermos, S. E. Waisbren, J. D. Faix and R. Z. Klein. 1999. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. NEJM 341( 8): 549 555.

Haut, M. J., P. P. Toskes, P. K. Hildenbrandt, B. E. Glader and M. E. Conrad. 1975. In vivo hepatic and intestinal toxicity of sodium cyanate in rats: cyanate induced alterations in hepatic glycogen metabolism. J Lab Clin Med 85( 1): 140 54.

Hauth, J. C., J. Hauth, R, B, Drawbaugh, L. C. Gilstrap III and W. P. Pierson. 1984. Passive smoking and thiocyanate concentrations in pregnant women and newborns. Obstet Gynecol 63( 4): 519 522. ( As cited in ATSDR, 1997.)

Haymaker, W., A. M. Ginzler and R. L. Ferguson. 1952. Residual Neuropathologial Effects of Cyanide Poisoning: A Study of the Central Nervous System of 23 Dogs Exposed to Cyanide Compounds. The Military Surgeon III( 4): 231 246.

Health Canada. 2001. Summary of guidelines for Canadian drinking water quality. Available at http:// www. hc sc. gc. ca/ ehp/ ehd/ bch/ water_ quality. htm Supporting documentation dated 7/ 91.

Heidelberger, C., A. E. Freeman, R. J. Pienta, A. Sivak, J. S. Bertram, B. C. Casto, V. C. Dunkel, M. W. Francis, T. Kakunaga, J. B. Little, and L. M. Schechtman. 1983. Cell transformation by chemical agents  a review and analysis of the literature. A report of the U. S. Environmental Protection Agency Gene Tox Program. Mutat Res 114: 283 385.

Heydens, W. F. 1985. Effects of thiocyanate on fetal and postnatal development and thyroid function in rats. Diss Abstr Int B 45: 2124.

Hill, R. N., L. S. Erdreich, O. E. Paynter, P. A. Roberts, S. L. Rosenthal and C. F. Wilkinson. 1989. Review: Thyroid follicular cell carcinogenesis. Fund Appl Toxicol 12: 629 697.

Himwich, W. A. and J. P. Saunders. 1948. Enzymatic Conversion of Cyanide to Thiocyanate. Am J Physiol 153: 348 354.

Hollowell, J. G., N. W. Staehling, W. H. Hannon, D. W. Flanders, E. W. Gunter, G. F. Maberly, L. E. Braverman, S. Pino, D. T. Miller, P. L. Garbe, D. M. DeLozier and R. J. Jackson. 1998. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III ( 1971 1974 and 1988 1994). J Clin Endocrinol Metab 83( 10): 3401 3408.

Holthman, S. B. and F. Schutz. 1948. Cyanase, a new enzyme catalyzing the hydrolysis of cyanate. Experientia 4: 398 399 ( As cited in Johnson et al., 1985).

Honig, D. H., M. E. Hockridge, R. M. Gould and J. J. Rackis. 1983. Determination of cyanide in soybeans and soybean products. J Agric Food Chem 31: 272 275. ( As cited in ATSDR, 1997.) Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 8 Howard, J. W. and R. F. Hanzal. 1955. Chronic toxicity for rats of food treated with hydrogen cyanide. Agric Food Chem 3( 4): 325 329.

Huang, J., H. Niknahad, S. Khan and P. J. O'Brien. 1998. Hepatocyte catalysed detoxification of cyanide by L and D cysteine. Biochem Pharmacol 55( 12): 1983 90.

IARC. 1992. International Agency for Research on Cancer. Occupational exposures to mists and vapours from sulfuric acid and other strong inorganic acids. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. 54: 41 130.

Jackson, L. C. 1988. Behavioral effects of chronic sublethal dietary cyanide in an animal model: Implications for humans consuming cassava ( Manihot esculenta). Hum Biol 60: 597 614.

Johnson, J. D., P. R. Mayer and G. E. Isom. 1985. Pharmacokinetic analysis of potassium cyanate in mice using whole blood and expired air. Drug Metabol Dispos 13 ( 2): 260 2.

Kamalu, B. P. 1993. Pathological changes in growing dogs fed on a balanced cassava ( Manihot esculenta Crantz) diet. Br J Nutr 69( 3): 921 934.

Kanno, J., C. Matsuoka, A. K. Furuta, H. Onodera, H. Miyajima, A. Maekawa and Y. Hayashi. 1990. Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol 18( 2): 239 246.

Kaplan, H. L. 1987. Effects of irritant gases on avoidance/ escape performance and respiratory response of the baboon. Toxicology 47( 1 2): 165 79.

Kaplan, H. L., A. Anzueto, W. G. Switzer and R. K. Hinderer. 1988. Effects of hydrogen chloride on respiratory response and pulmonary function of the baboon. J Toxicol Environ Health 23( 4): 473 93.

Kato, T., M. Kameyama, S. Nakamura, M. Inada and H. Sugiyama H. 1985. Cyanide metabolism in motor neuron disease. Acta Neurol Scand 72: 151 156.

Kawana, S. 1997. Drug eruption induced by cyanamide ( carbimide): A clinical and histopathologic study of 7 patients. Dermatology 195( 1): 30 4.

Kern, H. L., R. W. Bellhorn and C. M. Peterson. 1977. Sodium cyanate induced ocular lesions in the beagle. J Pharmacol Exp Therap 200( 1): 10 6.

Khandekar, J. D. and H. Edelman. 1979. Studies of amygdalin ( laetrile) toxicity in rodents. J Am Med Assoc 242: 169 171. ( As cited in ATSDR, 1997.)

Kier, L. D. 1988. Comments and perspective on the EPA workshop on " The relationship between short term information and carcinogenicity." Environ Mol Mutagen 11: 147 157. ( As cited in Rosenkranz and Klopman, 1990.) Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 9 Kihlman, B. A. 1957. Experimentally induced chromosome aberrations in plants. 1. The production of chromosome aberrations by cyanide and other heavy metal complexing agents. J Biophys Biochem Cytol 3: 363 380.

Kilburn, K. H. 1996. Effects of a hydrochloric acid spill on neurobehavioral and pulmonary function. J Occup Environ Med 38( 10): 1018 25.

Knowles, C. J. 1988. Cyanide utilisation and degradation by microorganisms. In: Cyanide compounds in biology. CIBA foundation symposium 140., Wiley, Chichester, pp. 3 15. ( As cited in ATSDR, 1997.)

Koibuchi, N. and W. W. Chin. 2000. Thyroid Hormone Action and Brain Development. Trends Endocrin Metab 11: 123 128.

Krasner, S. W., M. J. McGuire, J. G. Jacangelo, et al. 1989. The occurrence of disinfection byproducts in U. S. drinking water. J Am Water Works Assoc 81: 41 53.

Kreutler, P. A., V. Varbanov, W. Goodman, G. Olaya and J. B. Stanbury. 1978. Interactions of Protein Deficiency, Cyanide, and Thiocyanate on Thyroid Function in Neonatal and Adult Rats. Am J clin Nutr 31: 282 289.

Kushi, A., T. Matsumoto, and D. Yoshida. 1983. Mutagen from the gaseous phase of protein pyrolyzate. Agric Biol Chem 47: 1979 1982. ( As cited in ATSDR, 1997)

Laesch, E. E. and R. El Shawa. 1981. Multiple cases of cyanide poisoning by apricot kernels in children from Gaza. Pediatrics 68( 1): 5 7.

Les, E. P. 1968. Effect of acidified chlorinated water on reproduction in C3H/ HEJ and C57BL/ 6J mice. Lab Anim Care 18: 210 213.

Leuschner, J., A. Winkler and F. Leuschner. 1991. Toxicokinetic aspects of chronic cyanide exposure in the rat. Toxicol Lett 57( 2): 195 201.

Levin, B. C., M. Paabo, J. L. Gurman and S. E. Harris. 1987. Effect of exposure to single or multiple combinations of the predominant toxic gases and low oxygen atmospheres produced in fires. Fundam Appl Toxicol 9: 236 250.

Levis, A. G. and F. Majone. 1981. Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium. Br J Cancer 44: 219 235.

Lewis, J. L., C. E. Rhoades, P. G. Gervasi, W. C. Griffith and A. R. Dahl. 1991. The cyanidemetabolizing enzyme rhodanese in human nasal respiratory mucosa. Toxicol Appl Pharmacol 108( 1): 114 20.

Lide, D. R., ed. 1992. CRC Handbook of Chemistry and Physics, 73rd Edition. CRC Press, Inc. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 10 Liebowitz, D. and H. Schwartz. 1948. Cyanide poisoning: Report of a case with recovery. Am J Clin Pathol 18: 965 970.

Lijinsky W. and M. D. Reuber. 1982. Transnitrosation by nitrosamines in vivo. N nitroso compounds: occurence and biological effects. IARC Scientific Publications 41: 625 631.

Lijinsky, W. and R. M. Kovatch. 1989. Chronic toxicity tests of sodium thiocyanate with sodium nitrite in F344 rats. Toxicol Ind Health 5( 1): 25 29.

Lindberg, H. A., M. H. Wald and M. H. Barker. 1941. Observations on the pathologic effects of thiocyanate: an experimental study. Am Heart J 21: 605 616.

Lobert, J. M. and J. Warnatz. 1993. Emission from the combustion process in vegetation. In: P. J. Crutzen and J. G. Goldammer, eds.. Fire in the environment: The ecological, atmospheric and climatic importance of vegetation fires. John Wiley and Sons, pp. 15 37. ( As cited in ATSDR, 1997.)

Loomis, C. W. and J. F. Brien. 1983. Inhibition of hepatic aldehyde dehydrogenase in the rat by calcium carbimide ( calcium cyanamide). Can J Physiol Pharmacol 61: 1025 1034 ( As cited in Obach et al., 1989).

Loveless, L. E., E. Spoerl and T. H. Weisman. 1954. Survey of effects of chemicals on division and growth of yeast and escherichia coli. J Bacteriol 68: 637 644.

Lucas, A. D. 1992. Health hazards associated with the cyanotype printing process. J Environ Pathol Toxicol Oncol 11( 1): 18 20. ( As cited in ATSDR, 1997.)

McCarroll, N. E., C. E. Piper and B. H. Keech. 1981a. An E. coli microsuspension assay for the detection of DNA damage induced by direct acting agents and promutagens. Environ Mutagen 3: 429 444.

McCarroll, N. E., B. H. Keech and C. E. Piper. 1981b. Microsuspension adaptation of the Bacillus subtilis rec assay. Environ Mutagen 3: 607 616.

McDougall, P. T., N. S. Wolf, W. A. Stenback, and J. J. Trentin. 1967. Control of Pseudomonas aeruginosa in an experimental mouse colony. Lab Anim Care 17: 204 214.

McMahon, T. and L. Birnbaum. 1990. Age related changes in biotransformation and toxicity of postassium cyanide ( KCN) in male C57BL/ 6N mice [ Abstract]. In: Proceedings of the 29th Annual Meeting of the Society of Toxicology, Miami Beach, Fl.

Melzer M. S., R. T. Christian, J. F. Dooley, B. Schumann, H. L. Su, and S. Samuels. 1983. Mutagenicity of cyanate, a decomposition product of mnu. Mutat Res 116: 281 287. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 11 Menargues, A., R. Obach and J. M. Valles. 1984. An evaluation of the mutagenic potential of cyanamide using the micronucleus test. Mutat Res 136: 127 129.

Mertschenk, B., W. Bornemann, J. G. Filser, L. von Meyer, U. Rust, J. C. Schneider and C. Gloxhuber. 1991. Urinary excretion of acetylcyanamide in rat and human after oral and dermal application of hydrogen cyanamide ( H2NCN). Arch Toxicol 65( 4): 268 72.

Michigan Department of Public Health. 1977. Communication to the TLV committee. November. ( As cited in ACGIH, 1991).

Midwest Research Institute. 1997. In vitro study of cyanogen chloride in blood  amended report. NIEHS Contract No. N01 ES 55385. April 30, 1997.

Migridichian, V. 1946. The chemistry of organic cyanogen compounds. New York: Reinhold Publishing Corporation, pp. 102 116. As cited in U. S. EPA, 1990.

Mlingi, N., V. D. Vassey, A. B. M. Swai, et al. 1993. Determinants of cyanide exposure from cassava in konzo affected population in northern Tanzania. Int J Food Sci Nutr 44( 2): 137 144. ( As cited in ATSDR, 1997.)

Mlingi, N., N. H. Poulter and H. Rosling. 1992. An outbreak of acute intoxications from consumption of insufficiently processed cassava in Tanzania. Nutr Res 12( 6): 677 687. ( As cited in ATSDR, 1997.)

Morita, T., Y. Watanabe, K. Takeda and K. Okumura. 1989. Effects of pH in the in vitro chromosomal aberration test. Mutat Res 225: 55 60.

Morreale de Escobar, G., M. J. Obregon and F. Escobar del Ray. 2000. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975 3987.

Moudgal, C. J., J. C. Lipscomb, and R. M. Bruce. 2000. Potential health effects of drinking water disinfection by products using quantitative structure toxicity relationship. Toxicology 147: 109 131.

Müller, A. J. 1965. Arabidopsis Information Service. 6: 22 24. Unpublished article and no further information available. ( As cited in Rede, 1982).

Myers, P. R., D. E. Rawlings, D. R. Woods and G. G. Lindsey. 1993. Isolation and characterization of a cyanide dihydratase from Bacillus pumilus C1. J Bacteriol 175( 19): 6105 6112. ( As cited in ATSDR, 1997.)

Nagasawa, H., R. Yanai, Y. Nakajima, H. Namiki, S. Kikuyama and K. Shiota. 1980. Inhibitory effects of potassium thiocyanate on normal and neoplastic mammary development in female mice. Eur J Cancer 16( 4): 473 80. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 12 NAS. 1980. National Academy of Sciences. Drinking water and health, Vol. 3. Washington, DC: National Academy Press.

NAS. 1977. National Academy of Sciences. Drinking water and health. Washington, DC: National Academy Press.

NCI. 1979. National Cancer Institute. Bioassay of calcium cyanamide for possible carcinogenicity. Technical report series No. 163. National Toxicology Program.

Nicholson, D. H., D. R. Harkness, W. E. Benson and C. M. Peterson. 1976. Cyanate induced cataracts in patients with sickle cell hemoglobinopathies. Arch Ophthalmol 94( 6): 927 30.

NIOSH. 1990. National Istitute for Occupational Safety and Health. Unpublished provisional data as of 7/ 1/ 90, National Occupational Exposure Survey ( 1981 83). Cincinnati, OH. ( As cited in ATSDR, 1997.)

NIOSH. 1982. National Institute for Occupational Safety and Health. In depth survey report of American Airlines plating facility, NIOSH, Cincinnati, OH. PB83 187799, Springfield, VA. ( As cited in ATSDR, 1997.)

NIOSH. 1976. National Institute for Occupational Safety and Health. Health Hazard Evaluation Report No. 74 129 268, U. S. Dept. of Health, Education, and Welfare, Center for Disease Control, NIOSH, Cincinnati, OH. ( As cited in ATSDR, 1997.)

NRC. National Research Council. 1989. Recommended Dietary Allowances 10th edition, National Academy Press.

NTP. 1993. Technical Report on toxicity studies of sodium cyanide ( CAS No. 143 33 9) administered in drinking water to F344/ N rats and B6C3FI mice. N. I. H. Publication 94 3386. Public Health Service, National Institutes of Health, U. S. Department of Health and Human Services, National Toxicology Program.

Nylander, O., L. Holm, E. Wilander and A. Hallgren. 1994. Exposure of the duodenum to high concentrations of hydrochloric acid. Effects on mucosal permeability, alkaline secretion, and blood flow. Scand J Gastroentero 29( 5): 437 44.

Obach, R., A. Rives, J. M. Valles, A. Menargues, J. Prunonosa and J. Valles. 1985. Lack of hepatotoxicity after long term administration of cyanamide in rats: a histological and biochemical study. Acta Pharmacol Toxicol 57( 4): 279 84.

Obach, R., C. Valenti, J. Valles, J. M. Valles and J. Domenech. 1986a. Bioavailability of cyanamide in fasted and unfasted rats. Biopharm Drug Dispos 7( 3): 273 80. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 13 Obach, R., A. Menargues, J. Valles, J. M. Valles and J. A. Garcia Sevilla. 1986b. Effects of cyanamide on body weight and brain monoamines and metabolites in rats. Eur J Pharmacol 127( 3): 225 31.

Obach, R., H. Colom, J. Arso, C. Peraire, and J. Prunonosa. 1989. Pharmacokinetics of cyanamide in dog and rat. J Pharm Pharmacol 41: 624 627 O'Brien, G. M., L. Mbome, A. J. Taylor, et al. 1992. Variations in cyanogen content of cassava during village processing in Cameroon. Food Chem 44( 2): 131 136. ( As cited in ATSDR, 1997.)

Oh, M. S. 1994. Water, electrolyte, and acid base balance. In: Shiles, M. E., J. A. Olson, and M. Shike., eds. Modern nutrition in health and disease, 8th edition. Philadelphia: Lea & Febiger, pp. 134 135.

Ohio River Valley Water Sanitation Commission. 1982. Assessment of the water quality conditions: Ohio river mainstream 1980 81. Ohio River Valley Water Sanitation Comm., Cincinnati, OH. ( As cited in ATSDR, 1997.)

Ohnishi, A., C. M. Peterson and P. J. Dyck. 1975. Axonal degeneration in sodium cyanate induced neuropathy. Arch Neurol 32( 8): 530 4.

Ohya, T. and S. Kanno. 1987. Formation of cyanogen chloride during the chlorination of water containing aromatic compounds and ammonium ion. J Pharm Sci 76( 11).

Okoh, P. N. 1983. Excretion of 14 C labeled cyanide in rats exposed to chronic intake of potassium cyanide. Toxicol Appl Pharmacol 70: 335 339. ( As cited in ATSDR, 1997).

O'Neil, M. J., A. Smith, and P. E. Heckelman, eds. 2001. The Merck index   an encyclopedia of chemicals, drugs, and biologicals. 13th ed. Whitehouse Station, NJ: Merck& Co. P. 467.

Painter R. B. and R. Howard. 1982. The HeLa DNA synthesis inhibition test as a rapid screen for mutagenic carcinogens. Mutat Res 92: 427 437. ( As cited in ATSDR, 1997).

Palmer, I. S. and O. E. Olson. 1979. Partial prevention by cyanide of selenium poisoning in rats. Biochm Biophys Res Commun 90( 4): 1379 1386.

Palmer, R. S. and H. B. Sprague. 1929. Four cases illustrating the untoward symptoms which may be produced by the use of potassium sulfocyanate in the treatment of hypertension. M Clin North America 13: 215 220.

Palmer, R. S., L. S. Silver and P. D. White. 1929. Clinical use of potassium sulfocyanate in hypertension: a preliminary report of 59 cases. New Engl J Med 201: 709 714.

Pavlova, T. E. 1976. Disturbance of development of the progeny of rats exposed to hydrogen chloride. Bull Exp Biol Med ( USSR) 82: 1078 1081. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 14 Peterson, C. M., P. Tsairis, A. Onishi, Y. S. Lu and R. Grady. 1974. Sodium cyanate induced polyneuropathy in patients with sickle cell disease. Ann Intern Med 81( 2): 152 8.

Philbrick, D. J., J. B. Hopkins, D. C. Hill, J. C. Alexander and R. G. Thomson. 1979. Effects of prolonged cyanide and thiocyanate feeding in rats. J Toxicol Environ Health 5( 4): 579 92.

Porterfield, S. P. 1994. Vulnerability of the developing brain to thyroid abnormalities: Environmental insults to the thyroid system. Environ Health Perspect 102( Suppl. 2): 125 130.

Porterfield, S. P. 2000. Thyroidal dysfunction and environmental chemicals Potential impact on brain development. Environ Health Perspect 108( Suppl. 3): 433 438.

Potter, A. L. 1950. The successful treatment of two recent cases of cyanide poisoning. Br J Ind Med 7: 125 130.

Prentiss, A. M. 1937. Chemicals in war: A treatise on chemical warfare. Chapter VIII. Systemic toxic agents. New York: McGraw Hill Book Company, pp. 170 176.

Price, C. C., T. E. Larson, K. M. Beck, F. C. Harrington, L. C. Smith, and I. Stephanoff. 1947. Hydrolysis and chlorinolysis of cyanogen chloride. J Am Chem Soc 69: 1640 1644.

Purser, D. A., P. Grimshaw, and K. R. Berrill. 1984. Intoxication by cyanide in fires: a study in monkeys using polyacrylonitrile. Arch Environ Health 39: 394 400.

Pyska, H. 1977. Effect of thiocyanate on mammary gland growth in rats. J Dairy Res 44( 3): 427 31.

Raghunath, M. and T. S. Bala. 1998. Diverse effects of mild and potent goitrogens on bloodbrain barrier nutrient transport. Neurochem Int 33( 2): 173 7.

Rawson, R. W., J. F. Tannheimer and W. Peacock. 1944. The uptake of radioactive iodine by the thyroids of rats made goiterous by potassium thiocyanate and by thiouracil. Endocrinology 34: 245 253.

Redei, G. P. 1982. Mutagen assay with Arabidopsis. A report of the U. S. Environmental Protection Agency Gene Tox Program. Mutat Res 99: 243 255.

Reed, C. I. 1920. Chronic poisoning from cyanogen chloride. J Ind Hyg 2( 4): 140 143.

Research Triangle Institute. 1999. Perchlorate peer review workshop report. Reseach Triangle Park, NC: U. S. Environmental Protection Agency, Office of Solid Waste and Emergency Response. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 15 Richardson, S. D. 1998. Identification of drinking water disinfection byproducts. In: R. A. Meyers, ed. John Wiley's Encyclopedia of Environmental Analysis & Remediation. 3: 1398 1421. ( As cited in ATSDR, 1997.)

Robertson, S. A. 1989. Simple acid base disorders. Vet Clin North Am Small Anim Pract 19( 2): 289 306.

Rosenberg, N. L., J. A. Myers, and W. R. W. Martin. 1989. Cyanide induced parkinsonism clinical MRI and 6 fluorodopa Fd positron emission tomography pet studies. Neurology 39: 142 144.

Rosenkranz, H. S. and G. Klopman. 1990. Structural alerts to genotoxicity: The interaction of human and artificial intelligence. Mutagenesis 5: 333 361.

Rosling, H. 1987. Cassava toxicity and food security. A report for UNICEF African household food security programme. 2nd ed. Uppsala, Sweden: Tryck kontakt. pp. 1 40. ( As cited in ATSDR, 1997).

Russell, W. O. and W. C. Stahl. 1942. Fatal poisoning from potassium thiocyanate treatment of hypertension. J Am Med Assoc 119( 15): 1177 1181.

Saincher, A., N. Swirsky and M. Tenenbein. 1994. Cyanide overdose: Survival with fatal blood concentration without antidotal therapy. J Emerg Med 12( 4): 555 557.

Seigler, D. S. 1991. Cyanide and cyanogenic glycosides. In: Rosenthal, G. A., and M. R. Berenbaum, eds. Herbivores: Their interaction with secondary plant metabolites. New York, NY: Academic Press, pp. 35 77. ( As cited in ATSDR, 1997.)

Sellakumar, A. R., C. A. Snyder, J. J. Solomon and R. E. Albert. 1985. Carcinogenicity of formaldehyde and hydrogen chloride in rats. Toxicol Appl Pharmacol 81: 401 406.

Shirota, F. N., E. G. DeMaster and H. T. Nagasawa. 1987. Cyanide is a product of the catalasemediated oxidation of the alcohol deterrent agent, cyanamide. Toxicol Lett 37( 1): 7 12.

Shirota, F. N., H. T. Nagasawa, C. H. Kwon, and E. G. DeMaster. 1984. N acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man. Drug Metabol Dispos 12: 337 344. ( As cited in Obach et al., 1989).

Siemiatycki, J., ed. 1991. Risk factors for cancer in the workplace. Boca Raton, FL: CRC Press. ( As cited by IARC, 1992)

Sina, J. F., C. L. Bean, G. R. Dysart, V. I. Taylor, and M. O. Bradley. 1983. Evaluation of the alkaline elution/ rat hepatocyte asssay as a predictor of carcinogenic/ mutagenic potential. Mutat. Res 113: 357 391. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 16 Singh, B. M., N. Coles, P. Lewis, R. A. Braithwaite, M. Nattrass and M. G. FitzGerald. 1989. The metabolic effects of fatal cyanide poisoning. Postgraduate Med J 65( 770): 923 5.

Smith, A. G. and R. D. Rudolf. 1928. The use of sulphocyanate of soda in high blood pressure. Canadian Med Assoc J 19: 288 292.

Smyth, H. F., C. P. Carpenter, C. S. Weil, U. C. Pozzani, J. A. Striegel and J. S. Nycum. 1969. Range finding toxicity data: List VII. Am Ind Hyg Assoc J 30: 470 476. ( As cited in ATSDR, 1997.)

Stadelman, W. 1976. Content of hydrocyanic acid in stone fruit juices. Fluess Obst 43: 45 47. ( As cited in ATSDR, 1997/)

Stavert, D. M., D. C. Archuleta, M. J. Behr and B. E. Lehnert. 1991. Relative acute toxicities of hydrogen fluoride, hydrogen chloride, and hydrogen bromide in nose and pseudo mouthbreathing rats. Fund Appl Toxicol 16( 4): 636 55.

Stevens, B., J. Q. Koenig, V. Rebolledo, Q. S. Hanley and D. S. Covert. 1992. Respiratory effects from the inhalation of hydrogen chloride in young adult asthmatics. J Occup Med 34: 923 929.

Swain, E., C. P. LI and J. E. Poulton. 1992. Development of the potential for cyanogenesis in maturing black cherry ( Prunus serotina Ehrh.) fruits. Plant Physiol ( BETHESDA) 98( 4): 1423 1428. ( As cited in ATSDR, 1997)

Sylvester, M. and C. Sander. 1990. Immunohistochemical localization of rhodanese. Histochem J 22( 4): 197 200.

Taubman, G. and R. Heilborn. 1930. Untersuchungen zur Toxicologie des Natriumrhodanids. Arch Exper Path Pharmakol 152: 250. ( As cited in Lindberg, et al., 1941; study not available for review)

Teisseire, B. P., C. C. Vieilledent, L. J. Teisseire, M. O. Vallez, R. A. Herigault and D. N. Laurent. 1986. Chronic sodium cyanate treatment induces " hypoxia like" effects in rats. J Appl Physiol 60( 4): 1145 9.

Tellez, I., D. Johnson, R. L. Nagel and A. Cerami. 1979. Neurotoxicity of sodium cyanate. New pathological and ultrastructural observations in maccaca nemestrina. Acta Neuropathologica. 47( 1): 75 9.

Tellez Nagel, I., J. K. Korthals, H. V. Vlassara and A. Cerami. 1977. An ultrastructural study of chronic sodium cyanate indiuced neuropathy. J Neuropathol Exp Neurol 36( 2): 352 63.

Tewe, O. O. and J. H. Maner. 1981. Long term and carry over effect of dietary inorganic cyanide ( KCN) in the life cycle performance and metabolism of rats. Toxicol Appl Pharmacol 58: 1 7. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 17 Throssell, D., J. Brown, K. P. Harris and J. Walls. 1995. Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci 89( 6): 643 50.

Throssell, D., K. P. Harris, A. Bevington, P. N. Furness, A. J. Howie and J. Walls. 1996. Renal effects of metabolic acidosis in the normal rat. Nephron 73( 3): 450 5.

Tober Meyer, B. K., H. J. Bieniek and I. R. Kupke. 1981. Studies on the hygiene of drinking water for laboratory animals. 2. Clinical and biochemical studies in rats and rabbits during long term provision of acidified drinking water. Lab Anim 15( 2): 111 7.

Towill, L. E., J. S. Drury, B. L. Whitfield, et al. 1978. Reviews of the environmental effects of pollutants. V. Cyanide. Cincinnati, OH: EPA Health Effects Research Laboratory, Office of Research and Development. NTIS PB28 9920. ( As cited in ATSDR, 1997)

ToxiGenics, Inc. 1984. 90 Day inhalation study of hydrogen chloride gas in B6C3F1 mice, Sprague Dawley rats, and Fischer 344 rats. Study conducted for CIIT, Research Triangle Park, NC. CIIT Docket No. 20915.

Tylleskar, T., M. Banea, N. Bikangi, R. D. Cooke, N. H. Poulter and H. Rosling. 1992. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa [ published erratum appears Lancet 1992 Feb 15: 339( 8790): 440]. Lancet 339( 8787): 208 211. ( As cited in ATSDR, 1997)

Uitti, R. J., A. H. Rajput, E. M. Ashenhurst and B. Rozdilsky. 1985. Cyanide induced parkinsonism: A clinicopathologic report. Neurology 35( 6): 921 925.

U. S. EPA. 2001a. U. S. Environmental Protection Agency. Integrated Risk Information System ( IRIS). Online. Cyanide reference dose ( RfD). http:// www. epa. gov/ iris/ Verified 1985.

U. S. EPA. 2001b. U. S. Environmental Protection Agency. Help manual for Benchmark dose software version 1.3. Washington, DC: Office of Research and Development. EPA 600/ R 00/ 014F. Available at http:// cfpub. epa. gov/ ncea/ cfm/ bmds. cfm? ActType= default U. S. EPA. 2001c. U. S. Environmental Protection Agency. National Drinking Water Occurrence Database. http:// www. epa. gov/ ncod/

U. S. EPA. 2000a. U. S. Environmental Protection Agency. ICR data analysis plan. Office of Water.

U. S. EPA. 2000b. U. S. Environmental Protection Agency. Information collection rule ( ICR)  technical working group data analysis website. U. S. EPA. Available online at http:// www. cadmusonline. net/ twg/ mainmenu. htm U. S. EPA. 2000c. U. S. Environmental Protection Agency. Stage 2 Occurrence and exposure assessment for disinfectants and disinfection byproducts ( D/ DBPs) in public drinking water systems. Office of Ground Water and Drinking Water, Washington, D. C. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 18 U. S. EPA. 2000d. U. S. Environmental Protection Agency. Methodology for deriving ambient water quality criteria for the protection of human health. Office of Water, Office of Science and Technology, Washington, D. C. EPA 822 B 00 004.

U. S. EPA. 2000e. U. S. Environmental Protection Agency. Benchmark dose technical guidance document. External review draft. Washington, DC: Risk Assessment Forum.

U. S. EPA. 1999. U. S. Environmental Protection Agency. Guidelines for carcinogen risk assessment. Draft. NCEA F 0644.

U. S. EPA. 1997a U. S. Environmental Protection Agency. Risk assessment issue paper for: Derivation of a provisional RfD for thiocyanate. Superfund Technical Support Center, National Center for Environmental Assessment, Cincinnati, Ohio.

U. S. EPA. 1997b. U. S. Environmental Protection Agency. Volume I  General Factors, Exposure Factors Handbook, Update to Exposure Factors Handbook. EPA/ 600/ P 95/ 002Fa. Volume III  Activity Factors, Exposure Factors Handbook, Update to Exposure Factors Handbook  EPA/ 600/ P 95/ 002Fc. EPA/ 600/ 8 89/ 043  May 1989, Office of Research and Development, National Center for Environmental Assessment, U. S. Environmental Protection Agency, Washington, DC.

U. S. EPA. 1996. U. S. Environmental Protection Agency. Proposed Guidelines for Carcinogen Risk Assessment. Office of Research and Development, Washington, DC. EPA/ 600/ P 92/ 003C. April.

U. S. EPA. 1994a. U. S. Environmental Protection Agency. Final Draft for the Drinking Water Criteria Document on Chlorinated Acids/ Aldehydes/ Ketones/ Alcohols. Prepared for Health and Ecological Criteria Division Office of Science and Technology, Office of Water. Washington, DC. EPA 68 C2 0139.

U. S. EPA. 1994b. Environmental Protection Agency. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/ 600/ 8 90/ 066F.

U. S. EPA. 1993. U. S. Environmental Protection Agency. Reference dose ( RfD): Description and use in health risk assessments. Integrated Risk Information System ( IRIS). Online. Intra Agency Reference Dose Work Group, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office. Cincinnati, OH.

U. S. EPA. 1992. U. S. Environmental Protection Agency. Drinking water criteria document for cyanide. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Water. ECAO CIN 442.

U. S. EPA. 1990. U. S. Environmental Protection Agency. Reactions of cyanogen chloride. Office of Drinking Water, Criteria and Standards Division. TR 1242 58. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 19 U. S. EPA. 1988. U. S. Environmental Protection Agency. Recommendations for and documentation of biological values for use in risk assessment. Environmental Criteria and Assessment Office, Office of Research and Development. EPA/ 600/ 6 87/ 008, PB88 179874 U. S. EPA. 1987. U. S. Environmental Protection Agency. Rough Final Draft for the Drinking Water Criteria Document on Haloacetonitriles, Chloropicrin and Cyanogen Chloride. Prepared by ICAIR, Life Systems, Inc., for Criteria and Standards Division, Office of Drinking Water, Washington, DC, under Contract 68 03 3279.

U. S. EPA. 1986. U. S. Environmental Protection Agency. Guidelines for carcinogen risk assessment. Fed Reg 51( 185): 33992 34003.

U. S. EPA. 1980. U. S. Environmental Protection Agency. Water quality criteria documents: Availability. Fed Reg 45: 79318 79379.

U. S. FDA. 2002. U. S. Food and Drug Administration. History of FDA's Total Diet Study. http:// vm. cfsan. fda. gov/~ comm/ tds hist. html. Downloaded June 2002.

U. S. FDA. 1999. U. S. Food and Drug Administration. Economic characterization of the dietary supplement industry final report. Center for Food Safety and Nutrition. Available online: http:// www. csfan. fda. gov/~ comm/ ds econ4. html.

Valerdiz, S. and J. J. Vazquez. 1989. Cyanamide and its calcium form: do they differ with respect to their action on the liver cell? Experimental study in the rat. Appl Pathol 7( 6): 344 9.

Valles, J. R. Obach, A. Menargues, J. M. Valles and A. Rives. 1987. A two generation reproduction fertility study of cyanamide in the rat. Pharmacol Toxicol 61( 1): 20 5.

Vazquez, J. J., F. J. Guillen, J. Zozaya and M. Lahoz. 1983. Cyanamide induced liver injury. A predictable lesion. Liver 3( 4): 225 30.

Venier, P., A. Montaldi, L. Busi, C. Gava, L. Zentilin, G. Tecchio, V. Bianchi and A. G. Levis. 1985. Genetic Effects of Chromium Tannins. Carcinogenesis ( London) 6: 1327 1335.

Vesey, C. J., P. V. Cole and P. J. Simpson. 1976. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth 48( 7): 651 660. ( As cited in ATSDR, 1997)

Voldrich, M. and V. Kyzlink. 1992. Cyanogenesis in canned stone fruits. J Food Sci 57( 1): 161 162, 189. ( As cited in ATSDR, 1997)

WHO. 2000. World Health Organization. Environmental Health Criteria: 216 Disinfectant By products. Geneva, Switzerland. Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 20 WHO. 1998. World Health Organization. Guidelines for drinking water quality, 2nd ed. Vol. 2. Health criteria and other supporting information, 1996 ( pp. 940 949) and Addendum to Vol. 2 . 1998 ( pp. 281 283). Geneva, Switzerland.

WHO. 1992. World Health Organization. Technical Report Series 828. Evaluation of certain food additives and naturally occurring toxicants. Thirty ninth report of the Joint FAO/ WHO Expert Committee on food additives. Geneva, Switzerland. ( As cited in ATSDR, 1997)

Willhite, C. C., and R. P. Smith. 1981. The role of cyanide liberation in the acute toxicity of aliphatic nitriles. Toxicol Appl Pharmacol 59: 589 602. ( As cited in ATSDR, 1997)

Wilson, J. 1983. Cyanide in human disease: a review of clinical and laboratory evidence. Fundam Appl Toxicol 3: 397 399.

Wing, D. A. and S. I. Baskin. 1992. Modifiers of mercaptopyruvate sulfurtransferase catalyzed conversion of cyanide to thiocyanate in vitro. J Biochem Toxicol 7( 2): 65 72.

Wolff, J. 1998. Perchlorate and the thyroid gland. Pharmacol Rev 50: 89 105.

Wolff, J. and J. R. Maurey. 1963. Thyroidal iodide transport. IV. The role of ion size. Biochim Biophys Acta 69: 48 58.

Wolff, J., I. L. Chaikoff, A. Taurog and L. Rubin. 1946. The disturbance in iodine metabolism produced by thiocyanate: The mechanism of its goitrogenic action with radioactive iodine as indicator. Endocrinology 39: 140 148.

Wolfsie, J. H. and C. B. Shaffer. 1958. Hydrogen cyanide. Hazards, toxicology, prevention and management of poisoning. J Occup Med 2: 289 ( as cited by ACGIH, 1996).

Wood, J. L. 1975. Biochemistry. In: Newman, A. A., ed. Chemistry and biochemistry of thiocyanic acid and its derivatives. London: Academic Press, pp. 156 221.

Wu, W. W., P. A. Chadik, W. M. Davis, D. H. Powell and J. J. Delfino. 1998. Disinfection byproduct formation from the preparation of instant tea. J Agric and Food Chem 46( 8): 3272 3279.

Xie, Y., and D. A. Reckhow. 1993. A rapid and simple analytical method for cyanogen chloride and cyanogen bromide in drinking water. Water Res 27( 3): 507 511. ( As cited in ATSDR, 1997)

Yamanaka, S., S. Takaku, Y. Takaesu and M. Nishimura. 1991. Validity of salivary thiocyanate as an indicator of cyanide exposure from smoking. Bull Tokyo Dental Coll 32( 4): 157 163. ( As cited in ATSDR, 1997.) Drinking Water Criteria Document for Cyanogen Chloride and Potential Metabolites EPA/ OW/ OST/ HECD Final draft X 21 Yoon, J. S., J. M. Mason, R. Valencia, R. C. Woodruff and S. Zimmering. 1985. Chemical mutagenesis testing in drosophila. 4. Results of 45 coded compounds tested for the national toxicology program. Environ Mutagen 7: 349 367.

Young, M. S. and P. C. Uden. 1994. By products of the aqueous chlorination of purines and pyrimidines. Env Sci Tech 28( 9): 1755 1758.

Zeiger, E. 1987. Carcinogenicity of mutagens: Predictive capability of the salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res 47: 1287 1296.

Zeiger, E., B. Anderson, S. Haworth, T. Lawlor and K. Mortelmans. 1988. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 11( 12): 1 158.


[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Pages 45941-45946]
[FR Doc No: 2017-21053]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[U.S. DOT Docket Number NHTSA-2016-0065]

Reports, Forms, and Record Keeping Requirements

AGENCY: National Highway Traffic Safety Administration (NHTSA), U.S.
Department of Transportation.

ACTION: Request for comment on the renewal of collection of
information.

-----------------------------------------------------------------------

SUMMARY: Before a Federal agency can collect certain information from
the public, it must receive approval from the Office of Management and
Budget (OMB). Under procedures established by the Paperwork Reduction
Act of 1995, before seeking OMB approval, Federal agencies must solicit
public comment on proposed collections of information, including
extensions and reinstatement of previously approved collections.
    This document describes a collection of information for which NHTSA
intends to seek OMB approval.

DATES: Comments must be received on or before December 1, 2017.

ADDRESSES: You may submit comments using any of the following methods.
All comments must have the applicable DOT docket number (i.e., NHTSA-
2016-0065) noted conspicuously on them.
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting
comments.
     Mail: Docket Management Facility, M-30: U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery or Courier: 1200 New Jersey Avenue SE., West
Building Ground Floor, Room W12-140, Washington, DC 20590-0001, between
9 a.m. and 5 p.m. ET, Monday through

Friday, except Federal holidays. Telephone: 1-800-647-5527.
     Fax:<PHONE_NUMBER>.
    Instructions: All submissions must include the agency name and
docket number for this proposed collection of information. Note that
all comments received will be posted without change to http://www.regulations.gov, including any personal information provided.
Please see the Privacy Act heading below.
    Privacy Act: Anyone is able to search the electronic form of all
comments received into any of our dockets by the name of the individual
submitting the comment (or signing the comment, if submitted on behalf
of an association, business, labor union, etc.). You may review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477-78) or you may visit http://DocketInfo.dot.gov.
    Docket: For access to comments received, go to http://www.regulations.gov or the street address listed above. Follow the
online instructions for accessing the dockets.

FOR FURTHER INFORMATION CONTACT: For further information, or for
background documents, contact Stephen Hench, Office of Chief Counsel
(NCC-0100), Room W41-229, NHTSA, 1200 New Jersey Avenue SE.,
Washington, DC 20590. Telephone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995,
before an agency submits a proposed collection of information to OMB
for approval, it must first publish a document in the Federal Register
providing a 60-day comment period and otherwise consult with members of
the public and affected agencies concerning each proposed collection of
information. The OMB has promulgated regulations describing what must
be included in such a document. Under OMB's regulation, see 5 CFR
1320.8(d), an agency must ask for public comment on the following:
    (i) Whether the proposed collection of information is necessary for
the proper performance of the functions of the agency, including
whether the information will have practical utility;
    (ii) the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
    (iii) how to enhance the quality, utility, and clarity of the
information to be collected; and
    (iv) how to minimize the burden of the collection of information on
those who are to respond, including the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
    In compliance with these requirements, NHTSA asks for public
comments on the following collection of information:
    Title: Defect and Noncompliance Reporting and Notification.
    Type of Request: Renewal of a currently approved information
collection.
    OMB Control Number: 2127-0004.
    Affected Public: Businesses or individuals.
    Abstract: This notice requests comment on NHTSA's proposed renewal
to approved collection of information OMB No. 2127-0004. This
collection covers the information collection requirements found within
various statutory sections in the Motor Vehicle Safety Act of 1966
(Act), 49 U.S.C. 30101, et seq., that address and require manufacturer
notifications to NHTSA of safety-related defects and failures to comply
with Federal Motor Vehicle Safety Standards (FMVSS) in motor vehicles
and motor vehicle equipment, as well as the provision of particular
information related to the ensuing owner and dealers notifications and
free remedy campaigns that follow those notifications. The sections of
the Act imposing these requirements include 49 U.S.C. 30118, 30119,
30120, and 30166. Many of these requirements are implemented through,
and addressed with more specificity in, 49 CFR part 573, Defect and
Noncompliance Responsibility and Reports (Part 573) and 49 CFR 577,
Defect and Noncompliance Notification (Part 577).
    Pursuant to the Act, motor vehicle and motor vehicle equipment
manufacturers are obligated to notify, and then provide various
information and documents to, NHTSA in the event a safety defect or
noncompliance with Federal Motor Vehicle Safety Standards (FMVSS) is
identified in products they manufactured. See 49 U.S.C. 30118(b) and 49
CFR 573.6. Manufacturers are further required to notify owners,
purchasers, dealers, and distributors about the safety defect or
noncompliance. See 49 U.S.C. 30118(b), 30120(a); 49 CFR 577.7, 577.13.
Manufacturers are required to provide to NHTSA copies of communications
pertaining to recall campaigns that they issue to owners, purchasers,
dealers, and distributors. See 49 U.S.C. 30166(f); 49 CFR 573.6(c)(10).
    Manufacturers are also required to file with NHTSA a plan
explaining how they intend to reimburse owners and purchasers who paid
to have their products remedied before being notified of the safety
defect or noncompliance, and explain that plan in the notifications
they issue to owners and purchasers about the safety defect or
noncompliance. See 49 U.S.C. 30120(d) and 49 CFR 573.13. Manufacturers
are further required to keep lists of the respective owners,
purchasers, dealers, distributors, lessors, and lessees of the products
determined to be defective or noncompliant and involved in a recall
campaign, and are required to provide NHTSA with a minimum of six
quarterly reports reporting on the progress of their recall campaigns.
See 49 CFR 573.8 and 573.7, respectively.
    In addition, in an enforcement action, certain manufacturers may be
required by administrative order to conduct supplemental recall
communications utilizing non-traditional means (e.g., text messaging,
social media) crucial to achieving completion of a unique, large-scale
recall. Presently, NHTSA is overseeing recalls of unprecedented
complexity involving Takata air bag inflators, where it has required
such supplemental owner communications.\1\ NHTSA specifically seeks
comment on its estimates of the supplemental recall communications
associated with the Takata recalls.
---------------------------------------------------------------------------

    \1\ See ``Notice of Coordinated Remedy Program Proceeding for
the Replacement of Certain Takata Air Bag Inflator,'' available at
https://www.regulations.gov/docket?D=NHTSA-2015-0055.
---------------------------------------------------------------------------

    The Act and Part 573 also contain numerous information collection
requirements specific to tire recall and remedy campaigns. These
requirements relate to the proper disposal of recalled tires, including
a requirement that the manufacturer conducting the tire recall submit a
plan and provide specific instructions to certain persons (such as
dealers and distributors) addressing that disposal, and a requirement
that those persons report back to the manufacturer certain deviations
from the plan. See 49 U.S.C. 30120(d) and 49 CFR 573.6(c)(9). The
regulations also require that manufacturers report to NHTSA intentional
and knowing sales or leases of defective or noncompliant tires.
    49 U.S.C. 30166(n) and its implementing regulation found at 49 CFR
573.10 mandate that anyone who knowingly and willfully sells or leases
for use on a motor vehicle a defective tire or a tire that is not
compliant with FMVSS, and with actual knowledge that the tire
manufacturer has notified its dealers of the defect or noncompliance as
required under the Act, is required to report that sale or lease to
NHTSA no

more than five working days after the person to whom the tire was sold
or leased takes possession of it.
    Estimated Burden: The existing information collection associated
with 49 CFR part 573 and portions of 49 CFR part 577 currently has an
estimated annual burden of 36,070 hours associated with an estimated
275 respondents per year.\2\ Our prior estimates of the burden hours
and cost associated with the requirements currently covered by this
information collection require adjustment as follows.
---------------------------------------------------------------------------

    \2\ See 81 FR 70269 (October 11, 2016).
---------------------------------------------------------------------------

    Based on current information, we estimate 274 distinct
manufacturers filing an average of 963 Part 573 Safety Recall Reports
each year. This is a change from our previous estimate of 854 Part 573
Safety Recall Reports filed by 275 manufacturers each year. In
addition, with reference to the metric associated with NHTSA's VIN
Look-up Tool regulation, see 49 CFR 573.15, we continue to estimate it
takes the 17 major passenger-vehicle manufacturers (that produce more
than 25,000 vehicles annually) more burden hours to complete these
Reports to NHTSA. See 81 FR 70270 (October 11, 2016). Between 2014 and
2016, the major passenger-vehicle manufacturers conducted an average of
299 recalls annually.
    We continue to estimate that maintenance of the required owner,
purchaser, dealer, and distributors lists requires 8 hours a year per
manufacturer. We also continue estimate it takes a major passenger-
vehicle manufacturer 20 hours to complete each notification report to
NHTSA, and it takes all other manufacturers 4 hours. Accordingly, we
estimate the annual burden hours related to the reporting to NHTSA of a
safety defect or noncompliance for the 17 major passenger vehicle-
manufacturers to be 5,980 hours annually (299 notices x 20 hours/
report), and that all other manufacturers require a total of 2,656
hours annually (664 notices x 4 hours/report) to file their notices.
Accordingly, the estimated annual burden hours related to the reporting
to NHTSA of a safety defect or noncompliance is 10,828 hours (5,980
hours + 2,656 hours) + (274 MFRs x 8 hours to maintain purchaser
lists).\3\
---------------------------------------------------------------------------

    \3\ For more information about how we derived these and certain
other estimates please see 81 FR 70269 (October 11, 2016).
---------------------------------------------------------------------------

    We continue to estimate that an additional 40 hours will be needed
to account for major passenger-vehicle manufacturers adding details to
Part 573 Safety Recall Reports relating to the intended schedule for
notifying its dealers and distributors, and tailoring its notifications
to dealers and distributors in accordance with the requirements of 49
CFR 577.13. An additional 2 hours will be needed to account for this
obligation in other manufacturers' Safety Recall Reports. This burden
is estimated at 13,288 hours annually (664 notices x 2 hours/
notification) + (299 notices x 40 hours/notification).
    49 U.S.C. 30166(f) requires manufacturers to provide to the Agency
copies of all communications regarding defects and noncompliances sent
to owners, purchasers, and dealerships. Manufacturers must index these
communications by the year, make, and model of the vehicle as well as
provide a concise summary of the subject of the communication. We
continue to estimate this burden requires 30 minutes for each vehicle
recall. This totals an estimated 482 hours annually (963 recalls x .5
hours).
    In the event a manufacturer supplied the defective or noncompliant
product to independent dealers through independent distributors, that
manufacturer is required to include in its notifications to those
distributors an instruction that the distributors are to then provide
copies of the manufacturer's notification of the defect or
noncompliance to all known distributors or retail outlets further down
the distribution chain within five working days. See 49 CFR
577.7(c)(2)(iv). As a practical matter, this requirement would only
apply to equipment manufacturers since vehicle manufacturers generally
sell and lease vehicles through a dealer network, and not through
independent distributors. We believe our previous estimate of 95
equipment recalls per year needs to be adjusted to 87 equipment recalls
per year to better reflect recent data. Although distributors are not
required to follow that instruction, we expect that they will, and have
estimated the burden associated with these notifications (identifying
retail outlets, making copies of the manufacturer's notice, and
mailing) to be 5 hours per recall campaign. Assuming an average of 3
distributors per equipment item, (which is a liberal estimate given
that many equipment manufacturers do not use independent distributors)
the total number of burden hours associated with this third-party
notification burden is approximately 1,305 hours per year (87 recalls x
3 distributors x 5 hours).
    As for the burden linked with a manufacturer's preparation of and
notification concerning its reimbursement for pre-notification
remedies, we continue to estimate that the preparation of a
reimbursement plan takes approximately 4 hours annually, an additional
.5 hours per year is spent tailoring the plan to particular defect and
noncompliance notifications to NHTSA and adding tailored language about
the plan to a particular safety recall's owner notification letters,
and an additional 12 hours annually is spent disseminating plan
information, for a total 4,866 annual burden hours ((274 MFRs x 4 hours
to prepare plan) + (963 recalls x .5 hours tailoring plan for each
recall) + (274 MFRs x 12 hours to disseminate plan information)). For
more information about how we calculated these estimates please see the
Federal Register Notices 81 FR 70269 (October 11, 2016).
    The Safety Act and 49 CFR part 573 also contain numerous
information collection requirements specific to tire recall and remedy
campaigns, as well as a statutory and regulatory reporting requirement
that anyone who knowingly and intentionally sells or leases a defective
or noncompliant tire notify NHTSA of that activity.
    Manufacturers are required to include specific information related
to tire disposal in the notifications they provide NHTSA concerning
identification of a safety defect or noncompliance with FMVSS in their
tires, as well as in the notifications they issue to their dealers or
other tire outlets participating in the recall campaign. See 49 CFR
573.6(c)(9). We continue to estimate that the agency administers 12
tire recalls each year, on average. We continue to estimate that the
inclusion of this additional information will require an additional two
hours of effort beyond the subtotal above associated with non-tire
recall campaigns. This additional effort consists of one hour for the
NHTSA notification and one hour for the dealer notification for a total
of 24 burden hours (12 tire recalls a year x 2 hours per recall).
    Manufacturer-owned or controlled dealers are required to notify the
manufacturer and provide certain information should they deviate from
the manufacturer's disposal plan. Consistent with our previous
analysis, we continue to ascribe zero burden hours to this requirement
since to date no such reports have been provided and our original
expectation that dealers would comply with manufacturers' plans has
proven true.
    Accordingly, we continue to estimate 24 burden hours a year will be
spent complying with the tire recall campaign requirements found in 49
CFR 573.6(c)(9).

    The agency recently received one report under 49 U.S.C. 30166(n)
and its implementing regulation at 49 CFR 573.10 of a defective or
noncompliant tire being intentionally sold or leased, so our previous
estimate of zero burden hours for this regulatory requirement is being
revised. The agency estimates 1 burden hour annually will be spent
preparing and submitting such reports.
    We continue to believe nine vehicle manufacturers, who did not
operate VIN-based recalls lookup systems prior to August 2013, incur
certain recurring burdens on an annual basis. We continue to estimate
that 100 burden hours will be spent on system and database
administrator support. These 100 burden hours include: Backup data
management and monitoring; database management, updates, and log
management; and data transfer, archiving, quality assurance, and
cleanup procedures. We continue to estimate another 100 burden hours
will be incurred on web/application developer support. These burdens
include: Operating system and security patch management; application/
web server management; and application server system and log files
management. We continue to estimate these burdens will total 1,800
hours each year (9 MFRs x 200 hours). We continue to estimate the
recurring costs of these burden hours will be $30,000 per
manufacturer.\4\ We continue to estimate that the total cost to the
industry from these recurring expenses will total $270,000, on an
annual basis (9 MFRs x $30,000).
---------------------------------------------------------------------------

    \4\ $8,000 (for data center hosting for the physical server) +
$12,000 (for system and database administrator support) + $10,000
(for web/application developer support) = $30,000.
---------------------------------------------------------------------------

    Changes to 49 CFR part 573 in 2013 required 27 manufacturers to
update each recalled vehicle's repair status no less than every 7 days,
for 15 years from the date the VIN is known to be included in the
recall. This ongoing requirement to update the status of a VIN for 15
years continues to add a recurring burden on top of the one-time burden
to implement and operate these online search tools. We continue to
estimate that 8 affected motorcycle manufacturers will make recalled
VINs available for an average of 2 recalls each year and 19 affected
passenger-vehicle manufacturers will make recalled VINs available for
an average of 8 recalls each year. We believe it will take no more than
1 hour, and potentially much less with automated systems, to update the
VIN status of vehicles that have been remedied under the manufacturer's
remedy program. We continue to estimate this will require 8,736 burden
hours per year (1 hour x 2 recalls x 52 weeks x 8 MFRs + 1 hour x 8
recalls x 52 weeks x 19 MFRs) to support the requirement to update the
recalls completion status of each VIN in a recall at least weekly for
15 years.
    As the number of Part 573 Recall Reports has increased in recent
years, so has the number of quarterly reports that track the completion
of safety recalls. Our previous estimate of 3,800 quarterly reports
received annually is now revised upwards to 4,498 quarter reports
received annually. We continue to estimate it takes manufacturers 10
minutes to gather the pertinent information for each quarterly report,
and 4 additional hours for the 17 major passenger-vehicle
manufacturers. We therefore now estimate that the quarterly reporting
burden pursuant to Part 573 totals 818 hours ((4,498 quarterly reports
x 10 minutes/report) + (17 MFRs x 4 hours for electronic submission)).
    We continue to estimate a small burden of 2 hours annually in order
to set up a manufacturer's online recalls portal account with the
pertinent contact information and maintaining/updating their account
information as needed. We estimate this will require a total of 548
hours annually (2 hours x 274 MFRs).
    We continue to estimate that 20 percent of Part 573 reports will
involve a change or addition regarding recall components, and that at
one hour per amended report, this totals 193 burden hours per year (963
recalls x .20 = 193 recalls; 193 x 1 = 193 hours).
    As to the requirement that manufacturers notify NHTSA in the event
of a bankruptcy, we expect this notification to take an estimated 2
hours to draft and submit to NHTSA. We continue to estimate that only
10 manufacturers might submit such a notice to NHTSA each year, so we
calculate the total burden at 20 hours (10 MFRs x 2 hours).
    We continue to estimate that it takes manufacturers an average of 8
hours to draft their notification letters, submit them to NHTSA for
review, and then finalize them for mailing to their affected owners and
purchasers. We estimate that the 49 CFR part 577 requirements result in
7,704 burden hours annually (8 hours per recall x 963 recalls per
year).
    The burden estimate associated with the regulation that requires
interim owner notifications within 60 days of filing a Part 573 Safety
Recall Report must be revised upward. We previously calculated that
about 10 percent of past recalls require an interim notification
mailing, but recent trends show that 12 percent of recalls require an
interim owner notification mailing. We continue to estimate the
preparation of an interim notification can take up to 10 hours. We
therefore estimate that 1160 burden hours are associated with the 60-
day interim notification requirement (963 recalls x .12 = 116 recalls;
116 recalls times 10 hours per recall = 1160 hours).
    As for costs associated with notifying owners and purchasers of
recalls, we continue to estimate a cost of $1.50 per first class mail
notification, on average. This cost estimate includes the costs of
printing, mailing, as well as the costs vehicle manufacturers may pay
to third-party vendors to acquire the names and addresses of the
current registered owners from state and territory departments of motor
vehicles. In reviewing recent recall figures, we determined that an
estimated 75.8 million letters are mailed yearly totaling $113,700,000
($1.50 per letter x 75,800,000 letters). The requirement in 49 CFR part
577 for a manufacturer to notify their affected customers within 60
days would add an additional $13,644,000 (75,800,000 letters x .12
requiring interim owner notifications = 9,096,000 letters; 9,096,000 x
$1.50 = $13,644,000). In total, we estimate that the current 49 CFR
part 577 requirements cost manufacturers a total of $127,344,000
annually ($113,700,000 for owner notification letters + $13,644,000 for
interim notification letters = $127,344,000).
    NHTSA further has authority to require that, in an enforcement
action, vehicle manufacturers conduct supplemental recall
communications, potentially utilizing non-traditional means (e.g., text
messaging, social media). This is currently occurring in the Takata
recalls, which involve 19 vehicle manufacturers and over 46 million
defective inflators currently under recall in approximately 34 million
vehicles that need to be recalled as quickly as possible, given that
thirteen people in the United States have lost their lives to a
rupturing Takata inflator, and more than two hundred people have
reported associated injuries, many of which were disfiguring or life-
threatening. The scope of the Takata recall has been unprecedented in
the agency's history. Therefore, the below analysis only takes into
account the expected paperwork burden of this collection over the next
three years, without making any assumptions about the likelihood of
another large-scale recall that leads to similar types of supplementary
notices. However, the agency believes the lessons learned from the
Takata recall

will provide a useful guidepost in structuring any similar future
action.
    To address the scope and complexity of the Takata recall, NHTSA
issued a Coordinated Remedy Order, as amended on December 9, 2016 (the
``ACRO''), which requires affected vehicle manufacturers to conduct
supplemental owner notification efforts in coordination with NHTSA and
the Independent Monitor of Takata. On December 23, 2016, the Monitor,
in consultation with NHTSA, issued Coordinated Communications
Recommendations for vehicle owner outreach (``CCRs''), which includes a
recommendation that vehicle manufacturers provide at least one form of
consumer outreach per month for vehicles in a launched recall campaign
(i.e., a recall where parts are available) until the vehicle is
remedied (unless otherwise accounted for as scrapped, stolen, exported,
or otherwise unreachable under certain procedures in the ACRO). See
CCRs ]1(b); ACRO ]]45-46. The Monitor also recommended that
manufacturers utilize at least three non-traditional means of
communication (postcards; email; telephone calls; text message; social
media) as part of their overall outreach strategy. See CCRs ]1(a). And
the Monitor recommended including in these communications certain
content, including certain safety-risk information. See id. ]2. If a
vehicle manufacturer does not wish to follow the Monitor's
recommendations, the ACRO permits the manufacturer to propose an
alternative communication strategy to NHTSA and the Monitor.
    The Monitor's recommendations were adopted in significant part
because research supports that frequent notifications using non-
traditional means result in improved remedy completion.\5\ The agency
invites any additional feedback on the effectiveness of such outreach
in future enforcement actions, as well as the paperwork burden
associated with conducting that outreach.
---------------------------------------------------------------------------

    \5\ See, e.g., GM Safety Recalls: Innovations in Customer
Outreach (NHTSA Retooling Recalls Workshop, April 28, 2015)
(recognizing efficacy of various methods of owner engagement, and
citing customer recognition of GM's ``persistence'' through multiple
postcards and letters ``seal[ing] the deal'' for customer to seek
timely recall remedy); Auto Alliance & NADA Survey Key Findings
(November 2015), at 16 (observing dealers ``[t]ry multiple attempts
and methods [phone, email, mail] to contact customer'' when trying
to increase recall repair rates).
---------------------------------------------------------------------------

    To date, vehicle manufacturers and others have agreed that greater
notification frequency is preferred over less.\6\ However, the agency
is aware of generalized concerns about ``notification fatigue'' and
invites comment on this phenomenon, including the optimal frequency,
content, mode, and method of recall/defects notifications from
manufacturers to consumers. The agency is also particularly interested
any research or data that relates to a recall with potential
consequences of death or severe injury, as in the case of the Takata
recalls. NHTSA also seeks comment on the content and language to
include in these notifications, including relevant safety-risk
information, to increase the likelihood that consumers remedy the issue
as soon as possible.
---------------------------------------------------------------------------

    \6\ See, e.g., GM Safety Recalls, supra; Auto Alliance & NADA
Survey Key Findings, supra; GM letter to NHTSA in comment to ANPRM,
Docket No. NHTSA-2016-0001 (March 23, 2016), at 2 (``The best
approach is to leverage multiple communication channels and, where
possible, capture and use the customer's preferred method of
communication. In those cases where consumers perceive non-repair to
be low-risk, a ``saturation'' approach is sometimes effective. This
approach increases the frequency of contact and alternates the means
of communication.''); see also Susanne Schmidt & Martin Eisend,
Advertising Repetition: A Meta-Analysis on Effective Frequency in
Advertising, 44 J. Advertising 415, 425 (2015) (observing findings
``clearly support the repetitionists' view in the literature over
the minimalists' view: few exposures are not enough to achieve
maximum response, but repetition is essential for consumer
response''); id. at 426 (observing further that ``many exposures in
real-world settings are not completed (i.e. the consumer does not
read/watch/listen to an ad message in its entirety), and higher
exposure rates are necessary to reach optimum response''--
accordingly, the study's figures even ``might understate the optimum
exposure level needed in a real-world setting''); Blair Entenmann,
Marketing Help!, The Principles of Targeted Direct Mail Advertising
(2007) (``Timing may be a critical success factor--today they aren't
interested, but next month they might be. Repetition will generate a
better response.''); Chuck Flantroy, Direct Mail Works: The Power of
Frequency, Kessler Creative (August 31, 2016), available at http://www.kesslercreative.com/marketing-tips-tricks/direct-mail-works-the-power-of-frequency/ (observing that ``[a] huge factor to take into
account is the timing of . . . mailing(s). Even if your first
mailing falls on deaf ears, your second or third may come at just
the perfect time when a recipient of your campaign is in need of
your products or services'').
---------------------------------------------------------------------------

    NHTSA estimates a yearly average of 19 manufacturers will be
issuing monthly supplemental communications over the next three years
pursuant to the ACRO and the CCRs. Manufacturers may satisfy the CCRs
through third-party vendors (which have been utilized by many
manufacturers), in-house strategies, or some combination thereof. NHTSA
estimates the cost for supplemental communications at $0.44 per VIN per
month.
    The volume of outreach required by the ACRO and the CCRs (and the
costs associated with that outreach) is a function of the number of
unrepaired vehicles that are in a launched campaign and are not
otherwise accounted for as scrapped, stolen, exported, or otherwise
unreachable. The schedule in Paragraph 35 of the ACRO delineates the
expected remedy completion rate, by quarter, of vehicles in a launched
remedy campaign.
    Utilizing these variables, we estimate an initial annualized cost
over the next three years of $43,557,722 per year. However, NHTSA
anticipates that recent settlement agreements in the Southern District
of Florida multi-district litigation (MDL) governing economic-loss
actions against five manufacturer defendants will discount this figure
based on outreach efforts those defendants (Toyota, Subaru, Nissan,
BMW, Mazda, and Honda) are required to conduct pursuant to their
respective settlements. See generally In re: Takata Airbag Products
Liab. Litig., 14-cv-24009, MDL No. 2599 (S.D. Fla.). These outreach
programs are to utilize non-traditional methods of outreach, including
telephone, email, social media, and text messaging, and NHTSA
anticipates they will produce outreach that would satisfy the minimum
requirements of the CCRs. In calculating the estimated burden the
relevant manufacturers would have incurred under the same methodology
described above, NHTSA is discounting the annualized cost contemplated
by the ACRO and the CCRs by $15,721,393.
    Accordingly, NHTSA estimates the terms of ACRO and the CCRs,
assuming remedy-completion rates consistent with those prescribed in
the former, contemplate an annualized cost of $27,836,329 per year for
the next three years (2018-2020). In addition, NHTSA estimates that
manufacturers will take an average of 2 hours each month drafting or
customizing supplemental recall communications utilizing non-
traditional means, submitting them to NHTSA for review, and finalizing
them to send to affected owners and purchasers. NHTSA therefore
estimates that 456 burden hours annually are associated with issuing
these supplemental recall communications: 12 months x 2 hours per month
x 19 manufacturers = 456 hours.
    Because of the forgoing burden estimates, we are revising the
burden estimate associated with this collection. The 49 CFR part 573
and 49 CFR part 577 requirements found in today's notice will require
51,773 hours each year. Additionally, manufacturers impacted by 49 CFR
part 573 and 49 CFR part 577 requirements will incur a recurring annual
cost estimated at $127,614,000 total. The burden estimate in this
collection contemplated for conducting supplemental recall

communications under administrative order to achieve completion of the
Takata recalls is 456 hours each year. Additionally, that
administrative order contemplates impacted manufacturers incurring an
annual cost estimated at $27,836,329. Therefore, in total, we estimate
the burden associated with this collection to be 52,229 hours each
year, with a recurring annual cost estimated at $155,450,329.
    Estimated Number of Respondents--
    NHTSA estimates that there will be approximately 274 manufacturers
per year filing defect or noncompliance reports and completing the
other information collection responsibilities associated with those
filings. NHTSA estimates there will be an average of 19 manufacturers
each year conducting supplemental nontraditional monthly outreach
pursuant to administrative order in an enforcement action associated
with the Takata recall.

Jeffrey Giuseppe,
Acting Associate Administrator for Enforcement.
[FR Doc. 2017-21053 Filed 9-29-17; 8:45 am]
BILLING CODE 4910-59-P


20141 Federal Register / Vol. 68, No. 79 / Thursday, April 24, 2003 / Notices control number. The OMB control numbers for EPA's regulations are listed in 40 CFR part 9 and 48 CFR chapter 15. Burden Statement: The annual public reporting and recordkeeping burden for this collection of information is estimated to average 4.8 hours per response. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, or disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; develop, acquire, install, and utilize technology and systems for the purposes of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; adjust the existing ways to comply with any previously applicable instructions and requirements; train personnel to be able to respond to a collection of information; search data sources; complete and review the collection of information; and transmit or otherwise disclose the information. Respondents/ Affected Entities: Publicly owned treatment works ( POTWs), privately owned treatment works, new and existing industrial manufacturing and commercial discharger, storm water dischargers, treatment works treating domestic sewage ( TWTDS), and States and territories. Estimated Number of Respondents: 291,898. Frequency of Response: On occasion. Estimated Total Annual Hour Burden: 1,398,737 hours. Estimated Total Annual Cost: $ 53,546,024, includes $ 0 annualized capital or O& M costs. Changes in the Estimates: There is a decrease of 639,957 hours in the total estimated burden currently identified in the OMB Inventory of Approved ICR Burdens. This decrease in the applicant respondent and NPDES authorized state burden is due to a reduction in the burden associated with existing storm water permittees updating rather than developing Storm Water Pollution Prevention Plans.

Dated: April 10, 2003.

Oscar Morales,

Director, Collection Strategies Division. [ FR Doc. 03   10167 Filed 4   23   03; 8: 45 am]

BILLING CODE 6560   50   M ENVIRONMENTAL PROTECTION AGENCY [ OECA   2003   0003; FRL   7487   9]

Agency Information Collection Activities; Submission of EPA ICR No. 1061.09, OMB No. 2060   0037 to OMB for Approval; Comment Request AGENCY: Environmental Protection Agency ( EPA). ACTION: Notice.

SUMMARY: In compliance with the Paperwork Reduction Act ( 44 U. S. C. 3501 et seq.), this document announces that the following Information Collection Request ( ICR) has been forwarded to the Office of Management and Budget ( OMB) for review and approval: NSPS for the Phosphate Fertilizer Industry ( 40 CFR part 60, subparts T, U, V, W, and X), OMB Control No. 2060   0037, EPA ICR No. 1061.09. This ICR describes the nature of the information collection and its estimated burden and cost. DATES: Additional comments may be submitted on or before May 27, 2003. ADDRESSES: Follow the detailed instructions in the SUPPLEMENTARY INFORMATION.

FOR FURTHER INFORMATION CONTACT: Learia Williams, Compliance Assessment and Media Programs Division ( Mail Code 2223A), Office of Compliance, United States Environmental Protection Agency, 1200 Pennsylvania Avenue, NW. Washington, DC 20460; telephone number: ( 202) 564   4113; fax number: ( 202) 564   0050; e mail address: williams. learia@ epa. gov. SUPPLEMENTARY INFORMATION: EPA has submitted the following ICR to OMB for review and approval according to the procedures prescribed in 5 CFR 1320.12. On September 26, 2002 ( 67 FR 60672), EPA sought comments on this ICR pursuant to 5 CFR 1320.8( d). EPA received no comments. EPA has established a public docket for this ICR under Docket ID Number OECA   2003   0003, which is available for public viewing at the Enforcement and Compliance Docket and Information Center in the EPA Docket Center ( EPA/ DC), EPA West, Room B102, 1301 Constitution Avenue, NW., Washington, DC. The EPA Docket Center Public Reading Room is open from 8: 30 a. m. to 4: 30 p. m., Monday through Friday, excluding legal holidays. The telephone number for the Reading Room is ( 202) 566   1744, and the telephone number for the Enforcement and Compliance Docket and Information Center Docket is: ( 202) 566   1514. An electronic version of the public docket is available through EPA Dockets ( EDOCKET) at http:// www. epa. gov/ edocket. Use EDOCKET to submit or view public comments, access the index listing of the contents of the public docket, and to access those documents in the public docket that are available electronically. When in the system, select `` search,'' then key in the docket ID number identified above. Any comments related to this ICR should be submitted to EPA and OMB within 30 days of this notice, and according to the following detailed instructions: ( 1) Submit your comments to EPA online using EDOCKET ( our preferred method), by e mail to docket. oeca@ epa. gov, or by mail to: EPA Docket Center, Environmental Protection Agency, Mail Code: 2201T, 1200 Pennsylvania Avenue, NW., Washington, DC 20460, and ( 2) mail your comments to OMB at: Office of Information and Regulatory Affairs, Office of Management and Budget ( OMB), Attention: Desk Officer for EPA, 725 17th Street, NW., Washington, DC 20503. EPA's policy is that public comment, whether submitted electronically or on paper, will be available for public viewing in EDOCKET, as EPA receives them without change, unless the comment contains copyrighted material, Confidential Business Information ( CBI), or other information whose public disclosure is restricted by statute. When EPA identifies a comment containing copyrighted material, EPA will provide a reference to that material in the version of the comment placed in EDOCKET. The entire printed comment, including copyrighted material, will be available in the public docket. Although identified as an item in the official docket, information claimed as CBI, or whose disclosure is otherwise restricted by statute, is not included in the official public docket, and will not be available for public viewing in EDOCKET. For further information about the electronic docket, see EPA's notice describing the electronic docket at 67 FR 38102 ( May 31, 2002), or go to http:// www. epa. gov/ edocket. Title: NSPS for the Phosphate Fertilizer Industry ( 40 CFR part 60, subparts T, U, V, W, and X), OMB Control No. 2060   0037, EPA ICR No. 1061.09. This is a request to renew an existing, approved collection that is scheduled to expire on June 30, 2003. Under OMB regulations, the Agency may continue to conduct or sponsor the collection of information while this submission is pending at OMB. Abstract: The NSPS for the Phosphate Fertilizer Industry, published at 40 CFR part 60, subparts T, U, V, W, and X,

VerDate Jan< 31> 2003 18: 45 Apr 23, 2003 Jkt 200001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\ FR\ FM\ 24APN1. SGM 24APN1 20142 Federal Register / Vol. 68, No. 79 / Thursday, April 24, 2003 / Notices were proposed on October 22, 1974 and promulgated on August 6, 1975. These standards apply to each wet process phosphoric acid plant, each superphosphoric acid plant, each granular diammonium phosphate plant, and each triple superphosphate plant, having a design capacity of more than 15 tons of equivalent phosphorous pentoxide ( P2O5) feed per calendar day. These standards also apply to granular triple superphosphate storage facilities. Owners or operators of affected facilities described must make the following one time only initial notifications and reports on the results of the initial performance test. Owners or operators are also required to maintain records of the occurrence and duration of any startup, shutdown, or malfunction in the operation of an affected facility, or any period during which the monitoring system is inoperative. The owners or operators must install, calibrate, maintain, and operate a monitoring device which continuously measures and permanently records the total pressure drop across the scrubbing system. Also required are semiannual reports. The owner or operator subject to the provisions of this part shall maintain a file of these measurements, and retain the file for at least two years following the date of such measurements. Responses to the collection of information are mandatory and are being collected to assure compliance with 40 CFR part 60, subparts T, U, V, W, and X. These notifications, reports and records are essential in determining compliance. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control numbers for EPA's regulations are listed in 40 CFR part 9 and 48 CFR chapter 15, and are identified on the form and/ or instrument, if applicable. Burden Statement: The annual public reporting and recordkeeping burden for this collection of information is estimated to average 46 hours per response. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, or disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; develop, acquire, install, and utilize technology and systems for the purposes of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; adjust the existing ways to comply with any previously applicable instructions and requirements; train personnel to be able to respond to a collection of information; search data sources; complete and review the collection of information; and transmit or otherwise disclose the information. Respondents/ Affected Entities: Phosphate Fertilizer Industry. Estimated Number of Respondents: 13. Frequency of Response: Initial and Semiannual. Estimated Total Annual Hour Burden: 1,194. Estimated Total Annualized Operations and Maintenance Cost: $ 320,000. Changes in the Estimates: There is an increase of 231 hours and $ 320,000 in the total estimated burden currently identified in the OMB Inventory of approved ICR burdens. This is due to an increase in the number of sources and a reconsideration of the operation and maintenance costs for the required continuous emission monitors.

Dated: April 10, 2003. Oscar Morales, Director, Collection Strategies Division. [ FR Doc. 03   10171 Filed 4   23   03; 8: 45 am]

BILLING CODE 6560   50   P ENVIRONMENTAL PROTECTION AGENCY [ OPPT   2003   0018; FRL   7303   4]

National Tribal Conference on Environmental Management; Notice of Proposal Solicitation AGENCY: Environmental Protection Agency ( EPA). ACTION: Notice.

SUMMARY: EPA is requesting proposals from federally recognized Indian tribes or intertribal consortia to co sponsor the 7th National Tribal Conference on Environmental Management ( NTCEM). EPA will be the federal sponsor. The Tribal Conference will provide an opportunity for tribal leaders, tribal environmental managers, tribal organizations, federal agencies, and other interested entities/ persons to share information about tribal environmental programs and discuss issues of vital interest to Indian country. The scope of the conference traditionally encompasses multi media environmental issues involving tribes. The goals for the conference are to facilitate tribal environmental programs; establish stronger networks and relationships across environmental efforts in Indian country; identify shared lessons learned; and familiarize tribes with the full extent of tribal and EPA program environmental activities. EPA will award a cooperative agreement to the selected host tribe to co sponsor the conference, including personnel, planning, facilities, and management expenses.

DATES: Proposals must be received or postmarked byJune 23, 2003. A conference call for potential applicants to ask questions or seekpreapplication assistance is scheduled for May 7, 2003, from 2 p. m. to 4: 30 p. m. eastern standard time. Please call Caren Rothstein Robinson at ( 202) 564   0544 to obtain the conference call telephone number and the access code. ADDRESSES: Mail proposals via the U. S. Postal Service ( including express and priority mail) to: Clara Mickles, Environmental Protection Agency, American Indian Environmental Office, Mail code 4104M, 1200 Pennsylvania Ave., NW., Washington, DC 20460. Mail proposals via commercial overnight delivery service ( e. g., FedEx, DHL, UPS) to: Clara Mickles, Environmental Protection Agency, American Indian Environmental Office, Room 3334, EPA East, Mail code 4104M, 1201 Constitution Ave., NW., Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Caren Rothstein Robinson, Environmental Protection Agency, Office of Program Management Operations, Mail code 7101M, Office of Prevention, Pesticides and Toxic Substances, 1200 Pennsylvania Ave., NW., Washington, DC 20460; telephone number: ( 202) 564   0544. Applicants may submit written questions for clarification electronically to: rothstein robinson. caren@ epa. gov.

SUPPLEMENTARY INFORMATION:

I. General Information A. Does this Action Apply to Me?

This action is directed to the public in general. This action may, however, be of particular interest to federally recognized Indian tribes or tribal consortia. Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT.

B. How Can I Get Copies of This Document and Other Related Information?

1. Docket. EPA has established an official public docket for this action VerDate Jan< 31> 2003 18: 45 Apr 23, 2003 Jkt 200001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\ FR\ FM\ 24APN1. SGM 24APN1